Extended follow-up of DURVAST trial: A phase II study evaluating durvalumab treatment in HIV-1-infected patients with solid tumours by the Spanish lung cancer group
No Thumbnail Available
Identifiers
Date
2020-09-01
Authors
Gonzalez Cao, M.
Moran, T.
Dalmau, J.
Garcia-Corbacho, J.
Bernabe, R.
Juan Vidal, O. J.
de Castro Carpeno, J.
Blanco, R.
Drozdowskyj, A.
Meyerhans, A.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
